Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1734 (LINC01734)

Target: LINC01734
Molecular classification: Long non-coding RNA (lncRNA), Long intergenic non-coding RNA (lincRNA)

Overview

Long intergenic non-protein coding RNA 1734 (LINC01734) is a member of the long non-coding RNA (lncRNA) family, specifically categorized as a long intergenic non-coding RNA (lincRNA)[1][3][5]. These RNAs are defined as transcripts longer than 200 nucleotides that do not overlap protein-coding genes and do not encode proteins[5]. LINC01734 is transcribed from non-coding regions of the genome and, like other lincRNAs, may play roles in regulating gene expression at multiple levels, including transcriptional, post-trans

Other names: LINC01734Long intergenic non-protein coding RNA 1734

Mechanism of action

Not applicable (no known drugs directly target LINC01734)

Biological functions

Regulation of gene expression (transcription modulation, chromatin remodeling, enhancer activity, mRNA processing)Potential involvement in cell cycle regulation and cell-size control (based on studies of related lincRNAs in model organisms; not specific to LINC01734 but characteristic of the lincRNA family)Other (broad regulatory RNA function)

Disease associations

Other (Potential roles in cancer and other diseases are established for some lncRNAs and lincRNAs, but for LINC01734 specifically, no direct disease involvement has been described in the provided sources)

Safety considerations

None known (no therapeutics or interventions reported)

Biomarkers

Long non-coding RNAs, as a group, are being investigated as novel biomarkers for various diseases, including cancer, but LINC01734 itself is not specifically identified as a biomarker in the provided information

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1734 (LINC01734).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1734 (LINC01734).

Explore the full profile